An oral lecture on targeting NMDA Receptor 1A to ameliorate pain in chronic pancreatitis, marking a major milestone after three consecutive years of EPC visibility.
At the 57th European Pancreatic Club Meeting in Düsseldorf, our work on “Targeting N-Methyl-D-Aspartate Receptor 1A Ameliorates Pain in Mice with Chronic Pancreatitis” was presented as an oral lecture.
The study investigates mechanism-guided analgesic targeting in chronic pancreatitis, with a focus on NMDAR1A-associated neural signalling, pancreatic tissue pathology and neuropathic pain biology.
This presentation represented an important milestone following several years of visibility across European pancreatic disease meetings, including poster presentations, travel grant support and oral-stage recognition.